Spectrum Pharmaceuticals Inc. (SPPI)
$1.03
$0.00 (0.00%)As on 04-Aug-2023 09:30EDT
Market cap
$211 Mln
Revenue (TTM)
$26 Mln
P/E Ratio
--
P/B Ratio
2.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-56 Mln
-
ROE
-1.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.2
-
Debt to Equity
1.1
-
Book Value
$--
-
EPS
$-0.4
-
Face value
--
-
Shares outstanding
205,246,000
10 Years Aggregate
CFO
$-613.42 Mln
EBITDA
$-768.46 Mln
Net Profit
$-981.61 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Spectrum Pharmaceuticals (SPPI)
| 178.4 | 4.0 | -6.4 | 17.0 | -31.2 | -45.1 | -19.0 |
|
BSE Sensex*
| -9.1 | 2.1 | 5.9 | -6.0 | 6.9 | 8.0 | 11.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Spectrum Pharmaceuticals (SPPI)
| -70.9 | -62.8 | -6.3 | -58.4 | -53.6 | 327.8 | -26.5 |
|
S&P Small-Cap 600
| -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Spectrum Pharmaceuticals (SPPI)
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products. It offers ROLVEDON(Eflapegrastim), a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. The... company develops Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and license agreement with Therapyx, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Boston, Massachusetts. As of July 31, 2023, Spectrum Pharmaceuticals, Inc. operates as a subsidiary of Assertio Holdings, Inc. Read more
-
Pres, CEO & Director
Mr. Thomas J. Riga
-
Pres, CEO & Director
Mr. Thomas J. Riga
-
Headquarters
Boston, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Spectrum Pharmaceuticals (SPPI)
What is the current share price of Spectrum Pharmaceuticals Inc (SPPI) Today?
The share price of Spectrum Pharmaceuticals Inc (SPPI) is $1.03 (NASDAQ) as of 04-Aug-2023 09:30 EDT. Spectrum Pharmaceuticals Inc (SPPI) has given a return of -31.18% in the last 3 years.
What is the current PB & PE ratio of Spectrum Pharmaceuticals Inc (SPPI)?
Since, TTM earnings of Spectrum Pharmaceuticals Inc (SPPI) is negative, P/E ratio is not available.
The P/B ratio of Spectrum Pharmaceuticals Inc (SPPI) is 2.40 times as on 04-Aug-2023, a 44 discount to its peers’ median range of 4.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.87
|
2.43
|
|
2021
|
-1.24
|
4.13
|
|
2020
|
-2.82
|
3.59
|
|
2019
|
-2.99
|
2.13
|
|
2018
|
-7.70
|
3.26
|
What is the 52 Week High and Low of Spectrum Pharmaceuticals Inc (SPPI)?
The 52-week high and low of Spectrum Pharmaceuticals Inc (SPPI) are Rs -- and Rs -- as of 25-Jun-2026.
What is the market cap of Spectrum Pharmaceuticals Inc (SPPI)?
Spectrum Pharmaceuticals Inc (SPPI) has a market capitalisation of $ 211 Mln as on 04-Aug-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Spectrum Pharmaceuticals Inc (SPPI)?
Before investing in Spectrum Pharmaceuticals Inc (SPPI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.